Research map: Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics”

Back to the article

Papers in this map

  1. Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study · Jeffrey R. Bishop · 2024 · 9 citations · Cited by this paper
  2. A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End‐Stage Kidney Disease on Hemodialysis · 2026 · Related
  3. Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit /Hyperactivity Disorder · Cheng Shen · 2023 · 8 citations · Cited by this paper
  4. A Phase 1 Oral Mass Balance and Combined Intravenous [ 14 C] Microtracer Study to Characterize the Absorption, Metabolism, Excretion, and Pharmacokinetics of Antitumor Drug E7386 in Humans · 2026 · Related
  5. Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics · Kevin. V. Tobin · 2026 · 2 citations · Cited by this paper
  6. Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine · 2026 · Related
  7. 16.2 Dopamine Transporter and CYP2D6 Gene Effects on ADHD in the Methylphenidate and Atomoxetine Crossover Study · Mark Allen Stein · 2022 · 1 citation · Cited by this paper
  8. Volumetric Absorptive Microsampling During Spaceflight for Analysis of Acetaminophen Pharmacokinetics in Whole Blood · 2026 · Related
  9. Decoupling CAR‐T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi‐Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual Model · 2026 · Related
  10. Hepatic CYP1A2 Activity in Adolescents with and without Obesity Assessed by the Urinary Paraxanthine‐to‐Caffeine Metabolic Ratio: A Pharmacokinetic Study · 2026 · Related
  11. Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects · 2026 · Related
  12. Population Pharmacokinetics and Exposure‐Safety Analysis of Furosemide in Preterm Infants · 2026 · Related
  13. Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases · 2026 · Related

Source: OpenAlex (CC0)